Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Michelle Kumbier is Director at Abbott Laboratories. OQRO lists 2 transactions filed with the SEC under this name, the latest on Apr 28, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
As of the latest filing on , Michelle Kumbier reported holding 18,000 shares of Abbott Laboratories (ABT), worth about $1.88M at the last close of $104 (Nov 18, 2026). Holdings are also on file at Teledyne Technologies (TDY); together they are worth about $3.69M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Abbott Laboratories ABT | 18,000 | 18K direct | $104 | $1.88M | Apr 24, 2026 |
| Teledyne Technologies TDY | 2,888 | 2,888 direct | $628 | $1.81M | Apr 22, 2026 |
Is this Michelle Kumbier’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Michelle Kumbier bought shares on the open market in 2021, and has not bought since 2021 across 3 companies. Sales in 3 of the 11 years since 2016.
Michelle Kumbier reported 4 open-market purchases and 4 sales since 2016; purchases in 2021.
| Year | Bought | Sold |
|---|---|---|
| 2021 | $405K4×4 trades | — |
| 2019 | — | $816K1×1 trade |
| 2017 | — | $172K1×1 trade |
| 2016 |
Apr 24, 20262,286disclosed Apr 28
DetailsOfficial recordApr 22, 2026319disclosed Apr 23
DetailsOfficial record| — |
$1.33M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Apr 24, 2026, Michelle Kumbier reported holding 18,000 shares of Abbott Laboratories (ABT). At the last close of $104 on Nov 18, 2026, that is about $1.88M. This is the stake disclosed in filings, not a net worth.
No public filing gives Michelle Kumbier's net worth. What SEC Form 4 shows is the stock stake: 18,000 shares of Abbott Laboratories (ABT), about $1.88M at the last close, plus holdings in 1 other company, about $3.69M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Michelle Kumbier bought shares on the open market in 2021, and has not bought since 2021 across 3 companies. Sales in 3 of the 11 years since 2016.
In SEC filings since 2016: the latest open-market purchase is from 2021; the latest open-market sale is from 2019.
3 companies: Teledyne Technologies (TDY, 2021), Abbott Laboratories (ABT, 2021), Harley-Davidson (HOG, 2016–2019).
Michelle Kumbier reported 0 open-market purchases and 4 sales here, 2016 to 2019.
Michelle Kumbier reported 3 open-market purchases and 0 sales here, 2021.
Michelle Kumbier reported 1 open-market purchase and 0 sales here, 2021.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.